Immediate Impact

1 from Science/Nature 49 standout
Sub-graph 1 of 24

Citing Papers

Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
2 intermediate papers

Works of Veronica Schimp being referenced

A phase II, open-label, multicenter study of IMC-1121B (ramucirumab; RAM) monotherapy in the treatment of persistent or recurrent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal (PPC) carcinoma (CP12-0711/NCT00721162).
2012
Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas
2006

Author Peers

Author Last Decade Papers Cites
Veronica Schimp 100 115 85 20 350
G. Rangoni 86 66 140 26 350
Yun Fu 74 76 71 23 337
Soshi Kusunoki 121 50 95 27 308
Jakub Radziszewski 66 201 37 21 412
Paweł Sadłecki 99 57 111 33 398
Y Minagawa 143 82 116 19 354
Robyn Sayer 71 123 194 17 392
Geoffrey Otton 92 26 83 20 389
Jean-François Rodier 84 149 48 19 389
Cunxian Zhang 136 32 133 30 338

All Works

Loading papers...

Rankless by CCL
2026